Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Cash from Investing Activities (2009 - 2026)

Revvity's (RVTY) quarterly Cash from Investing Activities came in at -$3.5 million in Q3 2026, up 81.42% on a YoY basis from -$1.9 million in Q3 2025, and up 95.52% quarter-over-quarter from -$78.3 million in Q2 2026.

Analysis

Revvity (RVTY) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Revvity (RVTY) has reported Cash from Investing Activities for 18 consecutive years, with -$3.5 million the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Cash from Investing Activities rose 81.42% year-over-year to -$3.5 million; the trailing twelve-month figure through Jul 2026 stood at -$120.8 million (down 118.92% YoY), and the FY2025 full-year result was -$73.6 million, down 109.48% from the prior year.
  • Cash from Investing Activities advanced to -$3.5 million in Q3 2026 per RVTY's latest filing, from -$78.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $3.9 billion in Q1 2023 and bottomed at -$571.0 million in Q3 2023.
  • Historically, Cash from Investing Activities has averaged $362.4 million across 5 years, with a median of -$17.8 million in 2024.
  • The sharpest annual moves came in 2023 and 2026: Cash from Investing Activities surged 3411.37% in 2023, then slumped 396.87% in 2026.
  • Over 5 years, Cash from Investing Activities stood at -$56.3 million in 2022, then tumbled by 636.7% to -$414.8 million in 2023, then surged by 95.82% to -$17.3 million in 2024, then dropped by 18.02% to -$20.5 million in 2025, then surged by 82.86% to -$3.5 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$3.5 million, -$78.3 million, and -$20.5 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 164.00 Mn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -10.15 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -1.03 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -122.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -3.51 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -7.06 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -66.70 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -2.09 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -7.74 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -25.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 -3.51 Mn
Apr 5, 2026 -78.27 Mn
Dec 28, 2025 -20.45 Mn
Sep 28, 2025 -18.53 Mn
Jun 29, 2025 -18.87 Mn
Mar 30, 2025 -15.75 Mn
Dec 29, 2024 -17.33 Mn
Sep 29, 2024 690.18 Mn
Jun 30, 2024 121.49 Mn
Mar 31, 2024 -18.18 Mn
Dec 31, 2023 -414.81 Mn
Oct 1, 2023 434.87 Mn
Jul 2, 2023 -571.04 Mn
Apr 2, 2023 1.86 Bn
Jan 1, 2023 3.92 Bn
Apr 3, 2022 -56.31 Mn
Oct 3, 2021 -3.30 Bn
Jul 4, 2021 -290.03 Mn
Apr 4, 2021 -461.85 Mn
Jan 3, 2021 -436.40 Mn